Therapeutic trial of a combination of broxyquinoline and brobenzoxaldine in the treatment of leprosy.
D000328:Adult; D001565:Benzoates / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006912:Hydroxyquinolines / Q000008:administration & dosage*; D007918:Leprosy / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015125:Oxyquinoline / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000627:therapeutic use; D011798:Quinaldines / Q000008:administration & dosage* / Q000627:therapeutic use; D011804:Quinolines / Q000008:administration & dosage*; D013997:Time Factors
D001565:Benzoates; D006912:Hydroxyquinolines; D011798:Quinaldines; D011804:Quinolines; D015125:Oxyquinoline; C002276:broxyquinoline